The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin

EuroIntervention 2016;11:e1627-e1638 published online e-edition April 2016. DOI: 10.4244/EIJV11I14A314

1. Division of Cardiology, Mount Sinai School of Medicine, New York, NY, USA; 2. Center for Interventional Vascular Therapy, Columbia University, New York, NY, USA; 3. Cardiovascular Research Foundation, New York, NY, USA

Aims: Bivalirudin use as a procedural anticoagulant in patients undergoing percutaneous coronary intervention (PCI) is associated with a lower incidence of thrombocytopaenia compared to o

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study